In-Person Access Only | 6.00 CE/CME Credits & MOC Points
Please read: All programs remain free. Registrations will require a credit card as a cancellation hold. A fee of $50 will only be incurred in the event of a no-show or cancellation within 5 days without written confirmation to the Total Health Program Team.
Total Health’s 2027 ASCO Direct™ Gastrointestinal Cancer Conference is an officially licensed ASCO Direct™ meeting. This Post-ASCO Gastrointestinal Cancers Symposium Review highlights key abstracts from top-rated presentations, providing attendees with direct access to the latest research and strategies in GI oncology education. The accredited meeting will be hosted as an in person meeting only available exclusively to registered participants.
Conference Agenda
Saturday, February 20, 2027
Program Chairs:
Andrea Bullock, MD, MPH | Beth Israel Deaconess Medical Center
Jeffery Meyerhardt, MD, MPH, FASCO | Dana-Farber Cancer Institute
7:30 AM
Coffee and Exhibits
8:00 AM
Program Chair Welcome
Andrea Bullock, MD, MPH | Beth Israel Deaconess Medical Center
Jeffery Meyerhardt, MD, MPH, FASCO | Dana-Farber Cancer Institute
8:10 AM
The RAS Revolution in Pancreatic Cancer: Current Applications, Practical Management & What's Next
Andrea Bullock, MD, MPH | Beth Israel Deaconess Medical Center
8:30 AM
Precision Medicine in CRC: BRAF, RAS & Emerging Therapeutic Strategies
Jeffrey Meyerhardt, MD, MPH, FASCO | Dana-Farber Cancer Institute
8:50 AM
Rethinking Locally Advanced Rectal Cancer: TNT, ctDNA & Nonoperative Management
Christopher Cann, MD | Fox Chase Cancer Center
9:10 AM
ctDNA
Nilofer Azad, MD | Johns Hopkins
9:30 AM
Breakfast and Exhibits
9:45 AM
Non CME Breakfast - Revolution Medicines - Breaking Barriers in Pancreatic Adenocarcinoma by Targeting RAS
Shiraj Sen, MD, PhD | Texas Oncology - NEXT Oncology
10:30 AM
Break and Refreshments
10:40 AM
Immunotherapy & Cellular Therapy in CRC:
Rishi Surana, MD, PhD | Dana-Farber Cancer Institute
11:00 AM
HCC Across the Disease Continuum: Integrating Locoregional Therapy, Systemic Therapy & Immunotherapy
Kelsey Lau-Min, MD, MSCE | Massachusetts General Hospital
11:20 AM
Precision & Multimodality Treatment of Biliary Tract Cancers
James Cleary, MD, PhD | Dana-Farber Cancer Institute
12:20 PM
Lunch and Exhibits
12:35 PM
Non CME Lunch
1:20 PM
Break and Refreshments
1:30 PM
Housekeeping and Survey
2:20 PM
Upper GI Cancer in 2027: Biomarker Selection, Resistance, ADCs & Novel Targets
2:40 PM
Evolving Management of Neuroendocrine Tumors: Treatment Selection & Radioligand Therapy
Jonathan Strosberg, MD | Moffitt Cancer Center
3:00 PM
Emerging Science Across GI Oncology: Microbiome, Environmental Drivers & New Therapeutic Targets
Chaoyuan Kuang, MD, PhD | Albert Einstein College of Medicine
3:15 PM
Break and Exhibits
3:30 PM
Panel Discussion:
3:45 PM
Managing Treatment Related Toxicities in GI Oncology: Practical Strategies for Clinical Practice
4:25 PM
ADJOURN
Agenda Subject To Change. All times are EST.
-
Integrate new evidence into everyday clinical practice, thereby improving the quality of care being delivered to patients living with and beyond cancer.
Implement practice changes in a variety of treatment options for GI cancers.
Stimulate innovative strategies for new and additional research related to treatment and prevention.
Recognize the implications for practice change in both the academic and community practice settings.
-
-
Free registration for all healthcare providers
Expert sessions that present the most clinically relevant data, research, and clinical strategies
Real-time discussion and debate
Networking with peers, colleagues, and medical professionals
Access to the latest industry information and resources
Catered meals through-out the program